Maureen Kenny reports on efforts by the European Medicines Agency to ensure manufacturers of advanced therapies won't be caught out by approaching approval deadlines.
At least 20 advanced therapy medicinal products that are currently on the market in the EU will require formal centralised approval by the end of 2012 if they are to remain legally in use...
Please Login to read the full article.
